首页 | 本学科首页   官方微博 | 高级检索  
检索        


Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis
Institution:1. Department of Neurology Lahey Hospital and Medical Center, 41 Mall Road, Burlington, MA 01805, USA;2. Department of Neurology Tufts University Medical Center, 800 Washington Street, Boston, MA 02111, USA;3. Department of Neurosurgery Tufts University Medical Center, 800 Washington Street, Boston, MA 02111, USA;4. Department of Neurology Albany Medical Center Albany, NY 12208, USA;5. NYU Langone Medical Center Departments of Neurology and Neurosurgery New York, NY 10016, USA;1. Department of Head & Neck Surgery, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States;2. Department of Neurosurgery, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States;3. Department of Radiation Oncology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States;4. Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States;5. Department of Neurosurgery, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States;6. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States;1. Department of Neurosurgery, XiangYa Hospital, Central South University, Changsha, China;2. Department of Neurology, Hunan People’s Hospital, Changsha, China;3. Department of Epidemiology and Health Statistics, XiangYa School of Public Health, Central South University, Changsha, China;4. Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital), Changsha, China;5. The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, China;6. Hunan Provincial Key Laboratory of Clinical Epidemiology, XiangYa School of Public Health, Central South University, Changsha, China;1. Neurosurgery department, Beilinson Hospital, Rabin Medical Center, Tel-Aviv University, Petah Tikva, Israel;2. Pathology Department, Beilinson Hospital, Rabin Medical Center, Tel-Aviv University, Petah Tikva, Israel;3. Neuro-Oncology Center, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Tel-Aviv University, Petah Tikva, Israel;1. Spine Center, Konan Kosei Hospital, Konan, Japan;2. Department of Orthopedic Surgery, Nagoya University, Nagoya, Japan
Abstract:BackgroundMoyamoya disease is a chronic occlusive cerebrovascular disease that can present with either hemorrhagic or ischemic symptoms. The objective of this study was to evaluate whether the symptomatology of Moyamoya disease differs according to patient demographic groups.MethodsIn this study, we used the Nationwide Inpatient Sample (NIS) to investigate differences in the presentation of Moyamoya disease by age group, gender, and ethnicity from 2012 to 2016. After propensity score matching was utilized to control for overall comorbidity, the matched cohorts for each symptomatology were compared using a Chi-square test with respect to the potential risk factors of interest (i.e. age, sex, ethnicity) in order to generate multivariate reported P-values.ResultsA total of 4,474 patients met inclusion criteria. Patients presenting with ischemic stroke were more likely to be 65 years and older (p < 0.001); patients presenting with intracranial hemorrhage (ICH) were more likely to be 65 years and older (p < 0.001), male (p = 0.027), and Asian (p = 0.007); those presenting with seizure were more likely to be less than 10 years old (p = 0.002) and African American (p < 0.001); and those presenting with headache were more likely to be between 10 and 19 years old (p = 0.008).ConclusionsOur findings demonstrate that the distinct presentations of Moyamoya are associated with patient age, gender, and race. This is the largest study of its kind and adds to the collective understanding of this rare but life-threatening condition.
Keywords:Intracranial hemorrhage  Moyamoya disease  Racial disparities  Seizure  Stroke  ICD-9-CM"}  {"#name":"keyword"  "$":{"id":"k0035"}  "$$":[{"#name":"text"  "$$":[{"#name":"italic"  "_":"International Classification of Disease 9th edition Clinical Modification  ICD-10-CM"}  {"#name":"keyword"  "$":{"id":"k0045"}  "$$":[{"#name":"text"  "$$":[{"#name":"italic"  "_":"International Classification of Diseases 10th edition Clinical Modification  ICH"}  {"#name":"keyword"  "$":{"id":"k0055"}  "$$":[{"#name":"text"  "_":"Intracranial hemorrhage  MMD"}  {"#name":"keyword"  "$":{"id":"k0065"}  "$$":[{"#name":"text"  "_":"Moyamoya disease  NIS"}  {"#name":"keyword"  "$":{"id":"k0075"}  "$$":[{"#name":"text"  "_":"Nationwide Inpatient Sample  TIA"}  {"#name":"keyword"  "$":{"id":"k0085"}  "$$":[{"#name":"text"  "_":"Transient ischemic attack
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号